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INTRODUCTION
Paragonimiasis is an infectious disease caused by Paragoni­
mus. The infection is also known as the lung fluke or pulmo-
nary distomiasis because this trematode normally infects the 
lungs of mammals [1]. Human infection by the lung fluke Par­
agonimus westermani is endemic in East Asian and Southeast 
Asian countries [2-4]. Regardless of the species responsible for 
the infection, praziquantel is the standard treatment drug and 
it has a high cure rate [5]. Although praziquantel is regarded as 
safe, it can induce transient adverse reactions, such as abdomi-
nal pain, headache, dizziness, and diarrhea, although allergic 
reactions to praziquantel are very rare [6-8].
We report a case of complicated paragonimiasis in a Korean 
female who had a severe allergic reaction to praziquantel. Two 
courses of triclabendazole treatment failed to cure the infection. 
The patient was successfully treated with praziquantel follow-
ing a rapid desensitization procedure. 
CASE REPORT
The patient was a previously healthy 46-year-old female who 
had not traveled to any tropical area during the past 10 years. 
The patient was first admitted to the Department of Thoracic 
Surgery, Gachon University Gil Medical Center in mid-August, 
2008 with a chief complaint of a 7-day history of fatigue, cou-
ghing, and dyspnea on exertion. The patient had no fever or 
chest pain. The body temperature was normal, respiratory rate 
was 20 breaths/min, blood pressure was 110/80 mmHg, and 
pulse rate was 85 beats/min. The right side lung sounds were 
decreased. The patient’s total white blood cell (WBC) count 
was 10.24×10
3 cells/mm
3 with 24.6% eosinophils, and the 
erythrocyte sedmentation rate was 8 mm/hr. A chest radiograph 
show  ed a marked increase of pleural effusion in the right lung. 
There were no atypical cells in the pleural fluid, but many de-
generated leukocytes were observed. There was no evidence of 
malignancy. Chest CT of the thorax, which was taken after tube 
thoracotomy, revealed extensive subcutaneous emphysema in 
the upper trunk. Examination of stool and sputum samples 
for parasites and eggs was not performed at this time, and the 
symptom etiology remained unclarified. Seven days after the 
tube thorcotomy, the symptoms and roentgenographic abnor-
malities disappeared, and the patient was discharged.
On October, 2008, she visited our hospital again because of 
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generalized edema, itching, and migrating subcutaneous nod-
ules on the right flank area. The patient complained that these 
symptoms had persisted for about the previous 1 month. A 
chest roentgenogram was normal. The ultrasonogram for the 
right flank showed multiple intramuscular cystic masses that 
measured up to 1 cm. Although the peripheral blood eosino-
phil count was elevated (WBC 13.2×10
3 cells/mm
3, eosino-
phils 27%), the serum total IgE value (54.8 IU/mL) was in the 
normal range. Concerning dietary history, the patient had in-
gested incompletely cooked fresh water crab meat 18 months 
ago, which had been captured from the Sumjin River in South 
Korea. The serum was tested by microplate ELISA to establish 
a diagnosis of paragonimiasis [9]. The serum generated a strong 
positive reaction against Paragonimus westermani, with an opti-
cal density (OD) at 405 nm of 0.82 (cut-off OD: 0.25). Pra-
ziquantel was prescribed. Twenty min after taking the first dose 
of praziquantel (1,200 mg/2 tablets, Distocide®; Shinpoong 
Pharmaceutical Co., Seoul, Korea), the patient experienced a 
sudden onset of itching sensation, febrile sensation, wheal, 
and erythematous eruptions on the whole body, and painful 
swelling on the upper lip and both eyelids. Due of the serious-
ness of the symptoms, the patient was transferred to the emer-
gency department, where a diagnosis of an allergic or hyper-
sensitivity reaction induced by praziquantel was made. The 
patient received an injection of 3 mg of piprinhydrinate fol-
lowed by oral administration of 200 mg piprinhydrinate and 
200 mg cimetidine. One hour after receiving this medication, 
the itching sensation and skin eruption subsided. The patient 
denied any history of previous exposure to praziquantel. Seven 
days after this allergic reaction, the patient was given a 10 mg/
kg single dose of triclabendazole [10]. The itching sensation 
gradually disappeared over a period of 1 month after the med-
ication. However, the blood eosinophilia and intramuscular 
cystic masses in the right flank did not disappear over a period 
of 4 months after the medication.
On March, 2009 (6 months after the first visit), the patient 
was readmitted with recurrence of chest pain, coughing, and 
dyspnea on exertion. A chest radiograph demonstrated a large 
right-sided pneumothorax with new fluid collection. A tube 
thoracotomy was performed and this resolved the pneumo-
thorax. The peripheral blood eosinophil count (WBC 5.03×10
3 
cells/mm
3, eosinophils 33.1%) and the serum IgE value (652 
IU/ml) were elevated. Eosinophilia was also observed in the 
pleural effusion. P. westermani-specific IgG antibody reaction 
was strong in the serum (OD: 0.80) and the pleural effusion 
(OD: 0.70). The patient was treated again with triclabendazole 
(10 mg/kg once daily for 3 days) together with closed thora-
cotomy [11]. The patient was discharged on postoperative day 
7, and the chest radiograph at that time showed complete re-
expansion of the lung with no fluid.
On July, the patient revisited our department because of he-
moptysis and chest discomfort. A roentgenogram and CT con-
ducted at that time showed an approximately 3.2×2.8 cm het-
erogeneously enhanced mass-like consolidation in the anterior 
segment of the right upper lobe, which was attached to the me-
diastinal pleura (Fig. 1). The patient underwent a percutane-
ous needle biopsy of this lung lesion. The histologic findings 
showed abundant inflammatory cells, including many eosino-
phils, some granulomas, and necrotic cellular debris (Fig. 2). 
Parasitological examination of the stool and sputum showed 
negative results. Triclabendazole-resistant paragonimiasis was 
strongly suspected on the basis of the persistent eosinophilia 
(WBC 6.05×10
3 cells/mm
3, eosinophils 27%), radiological 
findings of the lung (Fig. 1), and histologic findings (Fig. 2). 
The P. westermani-specific IgG titer (OD: 0.77) was not decre-
ased com  pared with that noted in October, 2008 (Fig. 3). 
On the skin prick and intradermal tests with praziquantel, 
the patient revealed immediate hypersensitivity to the drug. 
We decided to try an oral desensitization to praziquantel ac-
cording to the modified desensitization protocol derived from 
White et al. [12], with increasing doses (30, 60, 100, 150, 300, 
600, and 1,200 mg) administered 90 min apart [12]. Thirty 
min after the 600 mg dose, she experienced an itching sensa-
Fig. 1. CT scan of the chest of a 46-year-old female diagnosed with 
P. westermani showed an approximately 3.2×2.8 cm sized hetero-
geneously enhanced mass-like consolidation (arrow) in the anterior 
segment of the right upper lobe, which was attached to the medi-
astinal pleura.  Kyung et al.: A paragonimiasis patient allergic to praziquantel   75
tion, fever (38.5˚C), wheal, and erythematous eruptions on 
the trunk, and swelling on the upper lip and both eyelids. She 
received an intravenous injection of 250 mg of hydrocortisone 
(Solucortef®), 3 mg of piprinhydrinate (Plakon®) and 50 mg 
of ranitidine. Two hours after receiving this medication, the al-
lergic symptoms and signs subsided. A therapeutic dose of pra-
ziquantel (75 mg/kg/day) was then given for 3 days without 
any symptoms of adverse reactions. The blood eosinophilia 
gradually normalized over a period of 2 months after the pra-
ziquantel treatment. 
The chest lesion and cystic mass-like lesions in the flank com-
pletely disappeared 4 months after the treatment. The patient 
remained well for the following 6 months. 
DISCUSSION
Human infection with P. westermani is acquired by ingesting 
fresh water crabs or crayfish that contain the metacercariae. 
Once ingested, the worms migrate through the intestinal wall 
to the peritoneal cavity, and then they cross the diaphragm and 
enter the pleural space and the lung parenchyma. The lung is 
the primary target of infection, although extrapulmonary in-
fections are also not uncommon [1,13]. The diagnosis is made 
by the identification of parasites or eggs in tissues, sputum, 
stool, or pleural fluid. Antibody test by ELISA is a valuable al-
ternative for diagnosing paragonimiasis [14,15]. Regardless of 
the species that is responsible for paragonimiasis, the standard 
treatment is chemotherapy with praziquantel (25 mg/kg twice 
a day, for 2 days) and this is effective in more than 90% of cas-
es. Triclabendazole (10-12.5 mg/kg/time), once or twice a day 
is recommended as an alternative drug of choice [10]. It is equ-
ally effective in deworming Paragonimus and it is better tolerat-
ed clinically than praziquantel [10]. The response to chemo-
therapy with these drugs can be followed by a downward trend 
of the peripheral eosinophilia and the antibody titer to Para­
gonimus, the cessation of passing eggs in the stool, and improve-
Fig. 2. Histologic findings of percutaneous needle biopsy specimens 
from the lung showed abundant inflammatory cells, including many 
eosinophils, some granulomas, and necrotic cellular debris. H-E 
stain, ×400.
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ment of radiological abnormalities [15,16]. 
The present case demonstrated complicated clinical features 
of paragonimiasis. The route of infection was suspected to be 
the ingestion of raw or incompletely cooked freshwater crab 
meat during a trip around the Sumjin River in South Korea 18 
months previously. At first, the patient was admitted due to 
pleural effusion. The results of pleural fluid analysis showed 
only degenerated leukocytes, but the patient had peripheral 
eosinophilia. The early phase of paragonimiasis involves larval 
migration within the peritoneal cavity, and penetration into 
the pleural cavity. In this phase, clinical symptoms are abdom-
inal pain, pleuritic chest pain, pneumothorax, or pleural effu-
sions. Leukocytosis and very prominent blood eosinophilia 
occur during this time. At that time, the patient’s clinical symp-
toms and marked eosinophilia originally suggested an early 
phase of paragonimiasis, but diagnostic evaluation for parasit-
ic infestation was not performed. Anti-parasitic treatment was 
delayed until 9 weeks because the patient underwent ELISA 
test at the second admission. The delay from the time of the 
first admission to anti-parasitic drug administration may have 
resulted in the patient’s complicated clinical course of P. wes­
termani infection. At the second admission, the patient com-
plained of a subcutaneous nodule on the right flank area. This 
lesion was an intramuscular cystic mass that was thought to be 
an extrapulmonary manifestation of paragonimiasis. Unfortu-
nately, the patient had an allergic reaction to paraziquantel and 
failed to clear the infection with triclabendazole treatments. 
During these periods, the patient showed hydropneumothorax 
and consolidation in the lung. When mature flukes inhabit the 
lungs during the late phase of paragonimiasis, patients display 
recurrent hemoptysis and radiologic findings of lungs, such as 
cystic cavities, parenchymal mass, or pleural thickening. Our 
patient showed pleural effusion, intramuscular mass, hydro-
pneumothorax, consolidative lesion in the lung, and persistent 
peripheral blood eosinophilia. We concluded that these all ma-
nifestations are caused by paragonimiasis. 
A search of the published literature showed that 4 cases of 
allergic reaction have been attributed to praziquantel treatment 
[6-8,17]. One report described a 10-year-old male with prazi-
quantel hypersensitivity. The patient was diagnosed as cysticer-
cosis and treated with praziquantel. The patient developed se-
vere urticaria during praziquantel administration. The authors 
tried desensitization of praziquantel with corticosteroids [8]. 
Another report described an 11-year-old male with schistoso-
miasis, who displayed fever, pruritus, and urticaric rash after 
praziquantel administration. This patient recovered after cessa-
tion of praziquantel treatment [17]. A third report described a 
male patient with clonorchiasis. The patient developed an ana-
phylactic reaction after praziquantel treatment and was treated 
with albendazole instead of praziquantel [6]. The anthelmin-
tic efficacy of praziquantel is due to the drug-related exposure 
of antigens on the tegument of mature and developing para-
sites [18]. However, it has been suggested that this immuno-
logic reaction to surface antigen from dead worms or eggs may 
induce host anaphylactic reaction caused by praziquantel [19]. 
In the present patient, the allergic reaction to praziquantel 
was demonstrated by skin testing, and the symptoms were re-
produced during the desensitization procedure. Although the 
patient denied previous praziquantel administration, it is pos-
sible that a previous exposure to the drug had occurred, pro-
ducing sensitization to the drug. 
To the best of our best knowledge, this is the first successful 
desensitization treatment with praziquantel that has been de-
scribed in the literature. Desensitization for drug allergy is the 
induction of temporary clinical unresponsiveness to drug anti-
gens [20]. Although the exact mechanism of this desensitiza-
tion is unknown, this can be achieved by administering gradu-
ally increasing doses of the allergenic drug at fixed time inter-
vals, and this desensitization allows use of a therapeutic dos-
age and avoidance of the previous severe drug allergies [12]. 
One case was previously treated using praziquantel desensiti-
zation [8]. However, it is unclear if true desensitization was 
ever achieved because that patient was concomitantly admin-
istrated with corticosteroids during desensitization [8]. 
In our case of paragonimiasis, the complicated clinical man-
ifestations may have been caused by the delayed diagnosis, the 
failure of triclabendazole treatment, and the allergic reaction 
to praziquantel. A desensitization procedure to praziquantel 
should be considered when no alternative drugs are available. 
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